Not applicableStudy completedNCT01976793What this trial is testingRetrospective Observational Study DIANA StudyWho this might be right forMajor Depressive Episode AstraZeneca 450
Large-scale testing (Phase 3)Study completedNCT01436149What this trial is testingEfficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderWho this might be right forMajor Depressive Disorder Shire 1,262
Not applicableUnknownNCT03227133What this trial is testingOral Fluency and the Response to Antidepressant Therapy in the Elderly With a Unipolar Depressive EpisodeWho this might be right forUnipolar Depression Centre Hospitalier Universitaire de Besancon 42
Testing effectiveness (Phase 2)Ended earlyNCT01554176What this trial is testingSafety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)Who this might be right forMajor Depressive Disorder, Recurrent Merck Sharp & Dohme LLC 129
Testing effectiveness (Phase 2)Study completedNCT01234558What this trial is testingSingle IV Dose of GLYX-13 in Patients With Treatment-Resistant DepressionWho this might be right forMajor Depressive Disorder Naurex, Inc, an affiliate of Allergan plc 115
Testing effectiveness (Phase 2)Study completedNCT03051256What this trial is testingSafety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDDWho this might be right forDepressive Disorder, MajorDepressive Disorder, Treatment-Resistant Relmada Therapeutics, Inc. 62
Post-approval studies (Phase 4)Study completedNCT01051466What this trial is testingThe Neurobiology of DepressionWho this might be right forMajor Depressive DisorderHealthy Participants Eli Lilly and Company 60
Testing effectiveness (Phase 2)Study completedNCT01912196What this trial is testingAdd-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)Who this might be right forMajor Depressive Disorder (MDD) MSI Methylation Sciences, Inc. 376
Large-scale testing (Phase 3)Study completedNCT00326105What this trial is testingEfficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive DisordersWho this might be right forMajor Depressive Disorder AstraZeneca 450
Testing effectiveness (Phase 2)Study completedNCT01435759What this trial is testingSPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderWho this might be right forMajor Depressive Disorder Shire 1,197
Testing effectiveness (Phase 2)Study completedNCT06340958What this trial is testingCLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive DisorderWho this might be right forAdjunctive Treatment of Major Depressive Disorder (MDD) Clexio Biosciences Ltd. 99
Post-approval studies (Phase 4)Study completedNCT05537584What this trial is testingSMART Trial to Predict Anhedonia Response to Antidepressant TreatmentWho this might be right forMajor Depressive Disorder Mclean Hospital 133
Post-approval studies (Phase 4)Study completedNCT00824044What this trial is testingQuantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in DepressionWho this might be right forMajor Depressive Disorder Massachusetts General Hospital 39
Large-scale testing (Phase 3)Study completedNCT01153347What this trial is testingAssess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderWho this might be right forMajor Depressive DisorderDepression AstraZeneca 2,409
Post-approval studies (Phase 4)Study completedNCT00304746What this trial is testingAndroGel in Men With Major Depression and Incomplete Response to Antidepressant TreatmentWho this might be right forDepressive Disorder, Major Mclean Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT01837797What this trial is testingEfficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentWho this might be right forMajor Depressive Disorder H. Lundbeck A/S 129
Testing effectiveness (Phase 2)Study completedNCT01437657What this trial is testingMARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant TherapyWho this might be right forMajor Depressive Disorder Hoffmann-La Roche 319
Large-scale testing (Phase 3)Study completedNCT03968159What this trial is testingAdjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant TreatmentWho this might be right forAdjunctive Treatment of Major Depressive Disorder ACADIA Pharmaceuticals Inc. 298
Post-approval studies (Phase 4)Study completedNCT04266288What this trial is testingEffectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency DepartmentWho this might be right forDepressionDepression SevereDepression Acute+2 more MercyOne Des Moines Medical Center 29
Post-approval studies (Phase 4)UnknownNCT01699490What this trial is testingRole of Inflammation Factors and Insulin Resistance in Major Depressive DisorderWho this might be right forMajor Depressive Disorder National Cheng-Kung University Hospital 200